Related content and features

BioPharm Insight

BioPharm Insight is the premier data and intelligence provider for Biotechs, Pharmas, CROs, Service Providers and financial professionals in the Healthcare and Medtech markets, which features proprietary, forward-looking intelligence, search functionality, a worldwide reference list of approved drugs and drug sales projections by indication.

BioPharm Insight’s comprehensive platform tracks the entire drug development pipeline from discovery and tech transfer platforms to approved drug licensing and generic formulations. Subscribers have access to:

• Detailed company profiles for over 4,200 Biotech and Pharmaceutical companies
• Contact information for 250,000+ industry contacts
• Exclusive, real-time intelligence from our global editorial team
• 36,000+ investigational drug profiles including development history, clinical trials, mechanisms, patent expiration dates, molecular structures, sales projections, and licensing deals
• 50,000+ approved drug profiles, foreign trade names, and marketing authorization by country

BioPharm’s team of specialized journalists provides global coverage of major medical conferences and material situations that highlight pivotal data presentations and analysis in advance of industry meetings and market-moving events. Areas of focus for the team include drug development, medical devices, diagnostics, M&A, licensing and financing, regulatory issues, litigation, and healthcare services.

To view all previous BioPharm Insight articles, please click here to go to the archive.

_____________________________________________________________

For more information

please email sales@biopharminsight.com
or call: Europe: 44 (0)20 7059 6202 USA: +1 781-762-8920

_____________________________________________________________